rs35313315
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_004268.5(MED17):c.1071T>A(p.Phe357Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00158 in 1,613,832 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004268.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED17 | ENST00000251871.9 | c.1071T>A | p.Phe357Leu | missense_variant | 7/12 | 1 | NM_004268.5 | ENSP00000251871.3 | ||
ENSG00000284057 | ENST00000638767.1 | c.1632T>A | p.Phe544Leu | missense_variant | 14/19 | 5 | ENSP00000492220.1 |
Frequencies
GnomAD3 genomes AF: 0.00803 AC: 1222AN: 152236Hom.: 18 Cov.: 33
GnomAD3 exomes AF: 0.00221 AC: 556AN: 251302Hom.: 5 AF XY: 0.00173 AC XY: 235AN XY: 135814
GnomAD4 exome AF: 0.000908 AC: 1327AN: 1461478Hom.: 11 Cov.: 31 AF XY: 0.000817 AC XY: 594AN XY: 727054
GnomAD4 genome AF: 0.00803 AC: 1223AN: 152354Hom.: 18 Cov.: 33 AF XY: 0.00805 AC XY: 600AN XY: 74504
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 25, 2013 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 11, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 17, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at